Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-131276
Filing Date
2021-10-28
Accepted
2021-10-28 20:58:54
Documents
2
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2131250-7_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2131250-7_3seq1.xml 3 7135
2 EXHIBIT 24 tm2131250d7_ex24.htm EX-24 9355
  Complete submission text file 0001104659-21-131276.txt   17879
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address
Dowden Nathan J (Reporting) CIK: 0001873392 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40969 | Film No.: 211360209